| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/05/2010 | US7642229 Synergistic antineoplastic effect; side effect reduction |
| 01/05/2010 | US7641925 Mixture of Trigonelline, amino acid and soluble fibers |
| 01/05/2010 | US7641924 Proteins, lipids and carbohydrates including glucose and fructose heterodisaccharides; slow hydrolysis |
| 01/05/2010 | US7641922 Preparation and application of transhintotalphenolic acid |
| 01/05/2010 | US7641919 Anti-bacterial plant compositions |
| 01/05/2010 | US7641917 to make an encapsulated product in particulate form; forming a mixture of a supercritical fluid, a polymeric encapsulating material and an active substance |
| 01/05/2010 | US7641915 Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules |
| 01/05/2010 | US7641914 Acid-sensitive compounds, their preparation and uses |
| 01/05/2010 | US7641909 Nonstructural and nonstructural proteins from attenuated dengue-2 virus, and structural protein from West Nile virus; vaccines |
| 01/05/2010 | US7641905 Methods of inducing an immune response |
| 01/05/2010 | US7641901 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 01/05/2010 | US7641894 Stimulating neutrophil function to treat inflammatory bowel disease |
| 01/05/2010 | US7641893 Polymerizable cyanoacrylate monomer and volatile liquid selected from linear and cyclic siloxanes, polydimethylsiloxanes, isooctane, and octane; kits |
| 01/05/2010 | US7641643 Methods and compositions to treat myocardial conditions |
| 01/05/2010 | CA2570474C A combination composition comprising paracetamol and ibuprofen |
| 01/05/2010 | CA2545999C 1,2-di(cyclic)substituted benzene compounds |
| 01/05/2010 | CA2473503C Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| 01/05/2010 | CA2465723C Process for reacting alkaloids and use of the reaction products in the preparation of medicaments |
| 01/05/2010 | CA2449098C Pharmaceutical compositions for the coordinated delivery of nsaids |
| 01/05/2010 | CA2429162C Methods and compositions for enhancing cellular function through protection of tissue components |
| 01/05/2010 | CA2426467C Composition comprising 8-prenylnaringenin for treatment of skin |
| 01/05/2010 | CA2426457C Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 01/05/2010 | CA2425319C Treatment and prophylaxis of diseases and infections of pigs and poultry |
| 01/05/2010 | CA2405796C Methods and compositions for modulating alpha adrenergic receptor activity |
| 01/05/2010 | CA2395601C Dibenzo (b,f) azepine intermediates |
| 01/05/2010 | CA2392081C Pharmaceutically active isoindoline derivatives |
| 01/05/2010 | CA2390100C Diaryl piperidyl pyrrole derivatives as antiprotozoal agents |
| 01/05/2010 | CA2383769C Indole derivatives |
| 01/05/2010 | CA2373757C Treatment of neurotic disorders |
| 01/05/2010 | CA2368583C New medicament compositions based on anticholinergically-effective compounds and .beta.-mimetics |
| 01/05/2010 | CA2358948C Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes |
| 01/05/2010 | CA2355584C Intraoral adhesive preparation |
| 01/05/2010 | CA2322168C Method for treating painful conditions of the anal region and compositions therefor |
| 01/05/2010 | CA2318192C .beta.2-adrenergic receptor agonists |
| 01/05/2010 | CA2236023C Method for enhancing dissolution properties of relatively insoluble dietary supplements and product incorporating same |
| 01/05/2010 | CA2185397C Arylalkyl-diazinones |
| 01/05/2010 | CA2175375C Glucosamine disaccharides, method for their preparation, pharmaceutical composition comprising same, and their use |
| 01/05/2010 | CA2164835C Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells |
| 12/31/2009 | US20090328243 Secreted proteins as markers for cell differentiation |
| 12/31/2009 | US20090327170 Methods of Clustering Gene and Protein Sequences |
| 12/31/2009 | US20090326633 Controlled release endoprosthetic device |
| 12/31/2009 | US20090326607 Electrical Stimulation Method for Treatment of Peripheral Neuropathy |
| 12/31/2009 | US20090326434 Anti-Microbial Photodynamic Therapy |
| 12/31/2009 | US20090326248 for treatment of insulin-like growth factor-1 receptor (IGF-1R) dependent diseases, such as cancer, psoriasis, atherosclerosis and acromegaly; preferred compound is picropodophyllin |
| 12/31/2009 | US20090326239 Fermentative preparation process for and crystal forms of cytostatics |
| 12/31/2009 | US20090326233 4-phenylpiperidine compounds |
| 12/31/2009 | US20090326225 Novel Process for the Preparation of Hexacyclic Compounds |
| 12/31/2009 | US20090326221 New oxabispidine compunds useful in the treatment of cardiac arrhythmias |
| 12/31/2009 | US20090326218 Azepinoindole and Pyridoindole Derivatives as Pharmaceutical Agents |
| 12/31/2009 | US20090326215 Glucopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture |
| 12/31/2009 | US20090326206 Single-chain Multiple Antigen-binding Molecule, Its Preparation and Use |
| 12/31/2009 | US20090326075 Enantiomers of o-desmethyl venlafaxine |
| 12/31/2009 | US20090326074 Alkoxy compounds for disease treatment |
| 12/31/2009 | US20090326073 Protection of normal cells |
| 12/31/2009 | US20090326072 USE OF 2-(2-NITRO-4-TRIFLUOROMETHYLBENZOYL)-l,3- CYCLOHEXANEDIONE IN THE TREATMENT OF PARKINSON'S DISEASE |
| 12/31/2009 | US20090326071 Method of feeding milk replacer with carnitine |
| 12/31/2009 | US20090326070 Vinyl substituted fatty acids |
| 12/31/2009 | US20090326069 Azelaic acid ester compositions and methods for diagnosing and treating tissue conditions using azelaic acid ester compositions and proteinaceous biomarkers |
| 12/31/2009 | US20090326068 Therapeutics for Cancer using 3-Bromopyruvate and other Selective Inhibitors of ATP Production |
| 12/31/2009 | US20090326067 Levodopa Prodrug Mesylate, Compositions Thereof, and Uses Thereof |
| 12/31/2009 | US20090326066 Process for preparing biaryl substituted 4-amino-butyric acid or derivatives thereof and their use in the production of nep inhibitors |
| 12/31/2009 | US20090326063 Synthetic triterpenoids and methods of use in the treatment of disease |
| 12/31/2009 | US20090326062 Process for preparing entacapone substantially free of z-isomer, synthesis intermediates thereof and a new crystalline form |
| 12/31/2009 | US20090326061 Apoptotic and anti-tumor activities of metallo-salens |
| 12/31/2009 | US20090326060 Method of Reversing, Preventing, Delaying or Stabilizing Soft Tissue Calcification |
| 12/31/2009 | US20090326059 Benzyloxy anilide derivatives useful as potassium channel modulators |
| 12/31/2009 | US20090326058 CaSR Antagonist |
| 12/31/2009 | US20090326057 Therapeutic uses of urolithins |
| 12/31/2009 | US20090326056 Novel actives against prostate carcinoma |
| 12/31/2009 | US20090326055 inhibiting the growth, delaying the progression or preventing the recurrence of androgen-independent prostate cancer tumor cells in a human comprising administering 2,2,5,7,8-pentamethyl-6-chromanol; anticarcinogenic agents |
| 12/31/2009 | US20090326053 Diagnostic uses of follistatin-like 1 |
| 12/31/2009 | US20090326052 Promoters exhibiting endothelial cell specificity and methods of using same |
| 12/31/2009 | US20090326050 Di(uridine 5'-)tetraphosphate and salts thereof |
| 12/31/2009 | US20090326049 Blocking oligos for inhibition of microrna and sirna activity and uses thereof |
| 12/31/2009 | US20090326047 Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin |
| 12/31/2009 | US20090326046 Methods and compositions for the specific inhibition of gene expression by double-stranded rna |
| 12/31/2009 | US20090326045 Compositions and methods for topical delivery of oligonucleotides |
| 12/31/2009 | US20090326044 RNAi-Mediated Inhibition of Ocular Targets |
| 12/31/2009 | US20090326043 Method and Compound for Antiviral (HIV) Therapy |
| 12/31/2009 | US20090326042 Compounds and methods for modulating expression of crp |
| 12/31/2009 | US20090326041 Compounds and methods for modulating expression of sglt2 |
| 12/31/2009 | US20090326040 Antisense modulation of apolipoprotein b expression |
| 12/31/2009 | US20090326039 Inhibitors for the soluble epoxide hydrolase |
| 12/31/2009 | US20090326038 Method for treating a immunology-related disease |
| 12/31/2009 | US20090326037 Medicinal Agent For Treating Viral Infections |
| 12/31/2009 | US20090326036 [2-(6-fluoro-1h-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders |
| 12/31/2009 | US20090326035 Compositions and Methods for Preventing or Reducing Postoperative Ileus and Gastric Stasis in Mammals |
| 12/31/2009 | US20090326034 Ketorolac tromethamine compositions for treating or preventing ocular pain |
| 12/31/2009 | US20090326033 Carvedilol |
| 12/31/2009 | US20090326032 Pharmaceutical compositions comprising nk1 receptor antagonists and sodium channel blockers |
| 12/31/2009 | US20090326031 Antiviral use of cationic surfactant |
| 12/31/2009 | US20090326030 Use of Levo-Ornidazole in the Preparation of Anti-Anaerobic Bacteria Infection Drugs |
| 12/31/2009 | US20090326029 Non-cyclic substituted benzimidazole thiophene benzyl ether compounds |
| 12/31/2009 | US20090326028 Process for the preparation of temozolomide and analogs |
| 12/31/2009 | US20090326027 N-Phenyl-2-0X0-1,4-Diazaspiro [4.5] Dec-3-EN-1-YL Acetamide Derivatives And Their Use As Glycine Transporter Inhibitors |
| 12/31/2009 | US20090326026 Tricyclic Compounds Useful as Angiotensin II Agonists |
| 12/31/2009 | US20090326025 New pharmaceutical composition |
| 12/31/2009 | US20090326024 Salts of imidazole-5-carboxylic acid derivatives, a method for preparing same and pharmaceutical compositions comprising same |
| 12/31/2009 | US20090326023 Indane Derivatives as Modulators of ION Channels |
| 12/31/2009 | US20090326021 Thiazolo naphthyl acids |